BTCS Sells Ethereum At Loss To Manage $64M Aave Loan Risk

11 min read
0 views
Nov 13, 2026

BTCS just sold Ethereum at a clear loss to shield a $64 million Aave loan. With ETH sliding and liquidation levels in sight, the latest filing reveals how close the position sits and what management did next.

Financial market analysis from 13/11/2026. Market conditions may have changed since publication.

Watching a company deliberately sell a core holding below its original cost always feels a bit unsettling, especially when that holding is Ethereum and the reason is pure risk management. That is exactly what BTCS, a Nasdaq-listed Ethereum treasury firm, just disclosed. In its latest quarterly filing the company confirmed it sold ETH at prices lower than what it paid in order to keep a sizable Aave loan from drifting into dangerous territory. The move was not forced liquidation. It was a calculated decision, and it tells us a lot about how some public crypto companies are navigating the current market.

Why BTCS Chose To Sell Ethereum Below Cost

The core issue is straightforward. BTCS carries a substantial borrowing position on Aave. As of November 9 the outstanding debt, including accrued interest, stood at roughly $64.1 million. That loan is backed by 46,676 ETH. At the then-prevailing price of about $2,127 those tokens were worth approximately $99.3 million, giving the position a collateral coverage of around 155 percent. On paper that still looks comfortable. In practice, with Ethereum prices under pressure, the buffer can shrink faster than many expect.

I have followed several of these treasury-style companies over the past couple of years, and the pattern is familiar. They accumulate ETH through a mix of equity raises, convertible notes, and decentralized lending. The leverage amplifies returns when prices rise. It also creates ongoing monitoring work when prices fall. BTCS has been transparent about that monitoring. The company stated it regularly reviews its borrowing positions and will adjust collateral or repay debt when market conditions demand extra protection against liquidation.

In this case the adjustment involved selling some ETH. The filing makes clear that those sales occurred at prices below the original cost basis. That is the part that catches attention. Realizing a loss is never pleasant, yet it can be the more responsible choice when the alternative is watching a health factor drift closer to the danger zone. According to the company, the sales formed part of its broader collateral management strategy rather than any emergency response to a margin call.

The Size Of The Position And How Close It Sits To Liquidation

Numbers help put the risk in perspective. Aave generally applies an 80 percent liquidation threshold for ETH collateral. Applying that threshold to the November 9 figures produces an estimated health factor of about 1.24. The corresponding liquidation price lands near $1,717 per ETH, assuming the loan balance, collateral amount, and protocol parameters stay unchanged. Of course those assumptions rarely hold perfectly. Interest continues to accrue, and the company can always add or remove collateral.

Still, the $1,717 level serves as a useful reference point. On November 13 Ethereum was trading near $1,932, down roughly 5.6 percent over the previous day. From that level the price would need to drop another 11 percent or so to reach the estimated liquidation zone. That is not an immediate crisis, but it is close enough that prudent management would want additional cushion. Selling some ETH and using the proceeds to reduce the loan or strengthen the remaining collateral is one way to buy that cushion.

Importantly, BTCS confirmed it has not experienced any full or partial liquidation events through November 11. The sales were voluntary. That distinction matters. Forced liquidations on Aave can be costly because of the discount applied to the collateral and the potential for cascading sales in thin markets. Avoiding that outcome is usually worth accepting a realized loss on a portion of the holdings.

What The Losses Actually Look Like On The Books

The filing also provides context on the scale of realized losses. During the first nine months of 2026 the company recorded approximately $30.6 million in realized digital asset losses. Those losses stemmed from two main activities: selling ETH to manage borrowing positions and recognizing accounting losses when transferring ETH into liquidity pools. The overall net loss for the nine-month period reached about $49.5 million, compared with a $52.2 million profit in the corresponding period a year earlier.

It is worth noting that the filing does not break out exactly how much ETH was sold specifically for the Aave position or what portion of the $30.6 million figure came from those particular sales. The lack of granular detail is common in these disclosures. Companies often prefer to keep tactical trading information at a higher level. From an investor’s perspective, though, the direction is clear. Management is willing to crystallize losses when necessary to protect the larger structure.

Cash on the balance sheet remains tight in traditional terms. At September 30 the company held only about $463,000 in cash and cash equivalents, down from $1.53 million at the start of the year. A substantial majority of its digital assets measured at fair value were deposited on Aave as collateral and therefore subject to protocol restrictions. Those assets cannot be freely used for general corporate purposes while the borrowings remain outstanding.

Yet the picture looks different when viewed through a broader liquidity lens. As of November 9 BTCS reported approximately $142.6 million in cash, stablecoins, and liquid digital assets. Total debt stood near $82 million, combining the $64.1 million Aave position with $17.9 million in convertible notes. In that light the company still maintains a meaningful cushion, even if much of it is tied up in restricted collateral.

How The Aave Borrowing Strategy Developed Over Time

BTCS did not stumble into this position overnight. Between January 1, 2025, and November 11, 2026, the company borrowed roughly $152.4 million in stablecoins through Aave and repaid about $89.4 million. The borrowings primarily involved USDT and GHO. Both are designed to hold a stable value relative to the dollar, while the ETH pledged as collateral fluctuates with market prices. That mismatch is the essence of the risk.

At the end of September the DeFi borrowing balance was already around $63 million. By early November it had edged up to $64.1 million including interest. Variable annual rates as of November 9 stood near 6.54 percent for USDT and 4.5 percent for GHO. Those rates move with utilization levels on the protocol, so the cost of capital is not fixed.

The borrowing strategy sits inside a larger effort to grow the company’s Ethereum holdings. In May 2025 BTCS arranged convertible financing to support additional purchases and validator operations. By July 2025 it had accumulated 55,788 ETH through a combination of equity financing, convertible debt, and DeFi borrowing. At September 30 total exposure reached 59,856 ETH, including 49,571 ETH held at fair value and another 10,285 ETH underlying liquidity pool positions.

In my view this approach is neither reckless nor especially conservative. It is a leveraged bet on Ethereum’s long-term trajectory, paired with active risk management. The recent sales show that management is prepared to take short-term pain to keep the longer-term structure intact. Whether that balance proves sustainable depends heavily on the path of ETH prices over the coming months.

Understanding The Health Factor And Why It Matters

For readers less familiar with Aave mechanics, the health factor is the key metric. It compares the value of collateral, adjusted by the liquidation threshold, against the amount owed. When the health factor drops below 1, the position becomes eligible for liquidation. Other market participants can then repay part or all of the debt and receive collateral at a discount. The process is automated and can happen quickly in volatile markets.

BTCS’s estimated health factor of 1.24 on November 9 left a reasonable but not enormous margin. Every percentage point decline in ETH price eats into that margin. Interest accrual slowly increases the debt side of the equation. That is why continuous monitoring is essential. The company has said it will adjust collateral or repay debt when conditions require additional protection. The recent ETH sales appear to be exactly that kind of adjustment.

One practical advantage of decentralized lending is the absence of fixed maturity dates. The Aave loans remain outstanding until the borrower chooses to repay or until liquidation occurs. There is no bank demanding repayment on a set schedule. The trade-off is the constant exposure to market-driven liquidation risk. For a company whose core business involves holding and operating Ethereum, that trade-off can make sense, provided the risk is managed tightly.

Broader Implications For Ethereum Treasury Strategies

BTCS is not the only public company running an Ethereum treasury strategy, but its willingness to disclose the details of collateral management is useful. It offers a window into the practical challenges of running leveraged crypto positions on the balance sheet of a regulated entity. Traditional finance has its own leverage tools, yet the transparency and speed of DeFi create a different set of pressures.

When prices are rising, the strategy looks brilliant. Collateral values expand, health factors improve, and the company can often borrow more to buy still more ETH. When prices fall, the same mechanics work in reverse. The decision to sell at a loss is the market’s way of forcing discipline. Companies that hesitate too long risk far larger losses through liquidation. Those that act early protect the remaining position at the cost of realized losses that appear in the financial statements.

I find the psychological aspect particularly interesting. Accepting a realized loss requires overcoming the natural reluctance to crystallize pain. Many holders prefer to wait for a recovery rather than sell below cost. Professional treasury management, however, prioritizes survival of the overall structure over the desire to avoid booking a loss. BTCS appears to have chosen the professional path in this instance.

Liquidity Position And Going-Concern Considerations

Despite the low cash balance at September 30, management expressed confidence that available resources and financing arrangements will support operations for at least the next twelve months, subject to market conditions. That statement is standard, yet it carries extra weight when a large portion of liquid assets is locked as collateral. The November 9 figure of $142.6 million in cash, stablecoins, and liquid digital assets provides the real comfort. Even after accounting for the Aave debt and convertible notes, the company retains meaningful flexibility.

The convertible notes of $17.9 million add another layer. Convertible instruments can convert into equity under certain conditions, potentially reducing cash repayment pressure. At the same time they introduce dilution risk for existing shareholders if conversion becomes attractive. Balancing those considerations is part of the ongoing capital structure work that any leveraged treasury company must perform.

Perhaps the most interesting aspect is how little traditional cash the company needs on a day-to-day basis. The bulk of its economic exposure sits in ETH, whether held outright, staked, or used as collateral. As long as the DeFi positions remain healthy and the broader market does not seize up, the low cash figure is less alarming than it would be for a conventional operating business with heavy working-capital needs.

What Investors Should Watch Next

Several variables will determine how this story develops. The first and most obvious is the price of Ethereum. A sustained recovery would improve collateral values, raise the health factor, and potentially allow the company to rebuild or even expand its position. Continued weakness would force further adjustments, possibly including additional sales at still lower prices.

The second variable is the company’s own behavior. Will management continue to sell opportunistically to keep the health factor comfortably above 1, or will it hold the line and accept tighter margins? The recent disclosure suggests a preference for proactive management. Future filings will show whether that preference remains consistent.

Interest rates on Aave also matter. Higher utilization can push borrowing costs up, slowly increasing the debt balance even without new draws. Lower rates ease the pressure. Because the loans have no fixed term, the cumulative interest cost over long periods can become material.

Finally, the broader regulatory and market environment for public crypto companies continues to evolve. Any change that affects the ability to hold or deploy digital assets, or that alters the attractiveness of convertible financing, could influence the strategy. For now the company appears focused on the immediate task of keeping its Aave position secure while maintaining a large Ethereum exposure.

Putting The Numbers In Context

It helps to step back from the daily price action and look at the scale. A $64.1 million loan secured by nearly 47,000 ETH is a meaningful position by most measures. The fact that the company was able to accumulate and then leverage that amount of Ethereum speaks to the maturation of both traditional capital markets access for crypto firms and the depth of decentralized lending protocols. At the same time, the need to sell at a loss underscores that leverage remains a double-edged sword.

The $30.6 million in realized losses over nine months is substantial relative to the company’s size. Yet it is still a managed outcome rather than a catastrophic one. No liquidations occurred. The remaining collateral continues to support the outstanding debt. Cash and liquid assets outside the restricted collateral provide additional optionality. In that sense the strategy has so far achieved its primary risk-management goal even while producing accounting losses.

I have seen similar dynamics play out with other leveraged crypto vehicles. The ones that survive drawdowns tend to be those willing to act early and accept temporary underperformance. The ones that fail often wait too long, hoping for a rebound that arrives too late. BTCS’s latest actions place it, for the moment, in the first group.

The Human Side Of Collateral Management

Behind the clinical language of health factors and liquidation thresholds sit real decisions made by real people. Someone had to approve the sale of ETH at a loss. Someone had to weigh the optics of realized losses against the risk of a more damaging liquidation event. Those conversations are rarely easy. In a rising market the same team is praised for aggressive accumulation. In a falling market the same discipline can look like capitulation.

That tension is inherent in any leveraged strategy. The filing’s relatively straightforward disclosure of the sales and the associated losses suggests management is comfortable owning the decision. Transparency of that sort is ultimately healthier for the market than silence or vague statements. Investors can disagree with the timing or the size of the sales, but at least they have the information needed to form a view.

Looking ahead, the next several months will test whether the current buffer is sufficient or whether further sales become necessary. Ethereum’s price path remains the dominant variable. Protocol parameters, interest rates, and the company’s own capital-raising ability form the secondary factors. For now the position appears managed rather than distressed, and that is the main takeaway from the latest filing.

The episode also serves as a reminder that even sophisticated treasury strategies are not immune to market gravity. Holding large amounts of a volatile asset and borrowing against it creates continuous work. When that work involves selling below cost, the headlines follow. The more important story is usually the one about whether the overall structure survives intact. On the evidence available so far, BTCS has kept its structure intact by accepting a measured amount of pain. That choice may prove wise if Ethereum stabilizes or recovers. If the decline deepens, the company will likely face similar decisions again, only from a lower starting point.

Either way, the filing offers a clear snapshot of how one public Ethereum treasury firm is handling the current environment. The combination of substantial DeFi borrowing, active collateral management, and willingness to realize losses when necessary paints a picture of pragmatic rather than purely opportunistic management. In a market that often rewards narratives over numbers, the numbers in this case are doing most of the talking.


As Ethereum continues to trade with elevated volatility, other companies running similar strategies will face comparable choices. Some will hold firm. Others will adjust early. The ones that communicate clearly about the trade-offs will give their shareholders the best chance to understand both the risks and the rationale. BTCS has provided that clarity in its latest disclosure. The market will decide in the coming months whether the decisions were well timed.

❝
The trouble for most people is they don't decide to get wealthy, they just dream about it.
— Michael Masters
Author

Steven Soarez passionately shares his financial expertise to help everyone better understand and master investing. Contact us for collaboration opportunities or sponsored article inquiries.

Related Articles

?>